Alere, Inc.
http://www.alere.com
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Alere, Inc.
Top 100 Review: The Calm Before The Storm – But Some Medtechs Already Reflect The Ravages Of COVID-19
2019 saw fewer revenues-boosting major acquisitions by top-tier medtechs. Companies that reported after the calendar year-end were the first to see the consequences of the pandemic on their annual figures.
MTI Top 100: Leading Medtechs See Steady Organic Growth In A Market On The Cusp Of Change
The disruptive medtech M&A of recent years was not matched in the past year for volume, but there were isolated outbreaks of major activity, as shown in our company rankings.
Medtech Veteran Robert Ford Will Take Over As Abbott CEO From Miles White
Abbott’s current COO Robert Ford will become the company’s new CEO on 31 March, 2020. Miles White is stepping down after 21 years leading the diversified health-care products company.
The Quality Lowdown: Quality Vision Falls Short At Various US and Indian Facilities
Court overrides stem cell clinic’s dismissal of drug GMPs, the US FDA upbraids drug makers for quality unit shortfalls, and a variety of snafus trigger drug recalls.
Company Information
- Industry
- Medical Devices
-
Pharmaceuticals
- Nutraceuticals
- OTC, Consumer
-
In Vitro Diagnostics
- Chemistry, Immunoassay
- Glucose Testing
- Urine-based Testing
- Other Names / Subsidiaries
-
- Axis-Shield plc
- Cholestech Corporation
- Free & Clear, Inc.
- Inverness Medical Innovations Inc.
- US Diagnostics (USD)
- Ostex International Inc.
- Binax, Inc.
- Biosite, Inc.